TransCode Therapeutics Reports Positive Data from First-in-Human Clinical Study Using Novel ...

BOSTON, May 29, 2024 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology company committed to more effectively treating cancer using RNA therapeutics, today announced new preliminary data

Related Keywords

Boston ,Massachusetts ,United States ,Tania Montgomery Hammon ,Daniel Vlock ,Zdravka Medarova ,Exchange Commission ,Transcode Therapeutics Inc ,Business Development ,Nasdaq ,Code Therapeutics ,Chief Scientific Officer ,Chief Medical ,Private Securities Litigation Reform Act ,Investigational New Drug ,Annual Report ,